RE:RE:Panc Phase 3This is pretty much the only thing they said in the entire call with regards to Panc Registrational Trial:
From Thomas H.
Updating us on an update. This compmay gets worse every day. It's not a scam but damn close, IMO.
They do anything and everything they can to secure next quarter's paychecks.
In closing I'd like to discuss our registrational plans for pela in pancreatic cancer. Our registrational strategy will focus on pela in combination with atezolizumab, gemcitabine and nab-paclitaxel in patients receiving first-line treatment for metastatic pancreatic cancer. We continued to develop a study protocol that utilizes an adaptive design building on the positive results from cohort 1 of the GOBLET study. We expect to provide an update on these plans this quarter.